Thiol/disulfide homeostasis as a novel indicator of oxidative stress in obstructive sleep apnea patients

Laryngoscope

Volumn 127, Issue 7, 2017, Pages E244-E250

  Dinc, Mehmet Emre ^a   Ozdemir, Cengiz ^c   Ayan, Nilhan Nurlu ^b   Bozan, Nazım ^d   Ulusoy, Seckin ^a   Koca, Cemile ^a   Erel, Ozcan ^e  

^a Head and Neck Surgery ^*  (Turkey)

^b Istanbul Gaziosmanpasa Taksim Training and Research Hospital Department of Biochemistry   (Turkey)

^c Yedikule Chest Diseases and Thoracic Surgery Training and Research Hospital   (Turkey)

^d YUZUNCU YIL UNIVERSITY   (Turkey)

^e Ankara yildirim Beyazit Research and training Hospital   (Turkey)

Author keywords

continuous positive airway pressure therapy; disulfide; obstructive; oxidative stress; Sleep apnea; thiol

Indexed keywords

DISULFIDE; THIOL; BIOLOGICAL MARKER; THIOL DERIVATIVE;

ADULT; APNEA HYPOPNEA INDEX; ARTICLE; CONTROLLED STUDY; FEMALE; HOMEOSTASIS; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OXIDATIVE STRESS; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SLEEP DISORDERED BREATHING; BLOOD; CASE CONTROL STUDY; PHYSIOLOGY; POLYSOMNOGRAPHY; SLEEP APNEA, OBSTRUCTIVE;

ADULT; BIOMARKERS; CASE-CONTROL STUDIES; CONTINUOUS POSITIVE AIRWAY PRESSURE; DISULFIDES; FEMALE; HOMEOSTASIS; HUMANS; MALE; MIDDLE AGED; OXIDATIVE STRESS; POLYSOMNOGRAPHY; PROSPECTIVE STUDIES; SLEEP APNEA, OBSTRUCTIVE; SULFHYDRYL COMPOUNDS;

EID: 85020912813     PISSN: 0023852X     EISSN: 15314995     Source Type: Journal    
DOI: 10.1002/lary.26444     Document Type: Article

References (25)

1. Lee W, Nagubadi S, Kryger MH, Mokhlesi B. Epidemiology of obstructive sleep apnea: a population-based perspective. Expert Rev Respir Med 2008;2:349–364.
2. Herrscher TE, Overland B, Sandvik L, Westheim AS, Akre H. High cardiovascular risk profile in patients with sleep apnea. Laryngoscope 2014;124:306–310.
3. Guo J, Sun Y, Xue LJ, et al. Effect of CPAP therapy on cardiovascular events and mortality in patients with obstructive sleep apnea: a meta-analysis. Sleep Breath 2016;20:965–974.
4. Gozal D, Kheirandish-Gozal L. Cardiovascular morbidity in obstructive sleep apnea: oxidative stress, inflammation, and much more. Am J Respir Crit Care Med 2008;177:369–375.
5. Suzuki YJ, Jain V, Park AM, Day RM. Oxidative stress and oxidant signaling in obstructive sleep apnea and associated cardiovascular diseases. Free Radic Biol Med 2006;40:1683–1692.
6. Peker Y, Hedner J, Norum J Kraiczi H, Carlson J. Increased incidence of cardiovascular disease in middle-aged men with obstructive sleep apnea: a 7-year follow-up. Am J Respir Crit Care Med 2002;166:159–165.
7. Berry RB, Budhiraja R, Gottlieb DJ, et al. American Academy of Sleep Medicine. Rules for scoring respiratory events in sleep: update of the 2007 AASM Manual for the Scoring of Sleep and Associated Events. Deliberations of the Sleep Apnea Definitions Task Force of the American Academy of Sleep Medicine. J Clin Sleep Med 2012;8:597–619.
8. Erel O, Neselioglu S. A novel and automated assay for thiol/disulphide homeostasis. Clin Biochem 2014;47:326–332.
9. Richards DCH, Jessup W, Dean RT. Cell surface proteins may be the primary targets during free radical-mediated cytolysis. Biochim Biophys Acta 1988;946:281–288.
10. Vince GS, Dean RT. Is enhanced free radical flux associated with increased intracellular proteolysis? FEBS Lett 1987;216:253–256.
11. Lavie L, Vishnevsky A, Lavie P. Evidence for lipid peroxidation in obstructive sleep apnea. Sleep 2004;27:123–128.
12. Barcelo A, Miralles C, Barbe F, Vila M, Pons S, Agusti AG. Abnormal lipid peroxidation in patients with sleep apnoea. Eur Respir J 2000;16: 644–647.
13. Carpagnano GE, Kharitonov SA, Resta O, Foschino-Barbaro MP, Gramiccioni E, Barnes PJ. 8-Isoprostane, a marker of oxidative stress, is increased in exhaled breath condensate of patients with obstructive sleep apnea after night and is reduced by continuous positive airway pressure therapy. Chest 2003;124:1386–1392
14. Celec P, Hodosy J, Behuliak M, et al. Oxidative and carbonyl stress in patients with obstructive sleep apnea treated with continuous positive airway pressure. Sleep Breath 2012;16: 393–398.
15. Yamauchi M, Nakano H, Maekawa J, et al. Oxidative stress in obstructive sleep apnea. Chest 2005;127:1674–1679.
16. Christou K, Markoulis N, Moulas AN, Pastaka C, Gourgoulianis KI. Reactive oxygen metabolites (ROMS) as an index of oxidative stress in obstructive sleep apnea patients. Sleep Breath 2003;7:105–110.
17. Schulz R, Mahamoudi S, Hattar K, et al. Enhanced release of superoxide from polymorphonuclear neutrophils in obstructive sleep apnea. Impact of continuous positive airway pressure therapy. Am J Respir Crit Care Med 2000;162:566–570.
18. Ozturk L, Mansour B, Yuskel M, Yalcin AS, Celicoglu F, Gokhan N. Lipid peroxidation and osmotic fragility of red blood cells in sleep apnea patients. Clin Chim Acta 2003;332:83–88.
19. Muns G, Rubinstein I, Bergmann KC. Phagocytocis and oxidative burst of blood phagocytes in chronic obstructive airway disease. Scand J Infect Dis 1995;27:369–373.
20. Wali SO, Bahammam AS, Massaeli H, et al. Susceptibility of LDL to oxidative stress in obstructive sleep apnea. Sleep 1998;21:290–296.
21. Dyugovskaya L, Lavie P, Lavie L. Increased adhesion molecules expression and production of reactive oxygen species in leukocytes of sleep apnea patients. Am J Respir Crit Care Med 2002;165:934–939.
22. Oyama J, Yamamoto H, Maeda T, Ito A, Node K, Makino N. Continuous positive airway pressure therapy improves vascular dysfunction and decreased oxidative stress in patients with the metabolic syndrome and obstructive sleep apnea syndrome. Clin Cardiol 2012;35:231–236.
23. Buechner NJ, Quack I, Woznowski M, Stahle C, Wenzel U, Rump LC. Microvascular endothelial dysfunction in obstructive sleep apnea is caused by oxidative stress and improved by continuous positive airway pressure therapy. Respiration 2011;82:409–417.
24. Kohler M, Stoewhas AC, Ayers L, et al. Effects of continuous positive airway pressure therapy withdrawal in patients with obstructive sleep apnea: a randomized trial. Am J Respir Crit Care Med 2011;184:1192–1199.
25. Kanimozhi S, Balaji C, Saravanan A, Ravi K. Effect of short term CPAP therapy in obstructive sleep apnea patients with metabolic syndrome. J Clin Diagn Res 2015;9:CC07–CC10.